Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Cerebral Cortex (New York, N.Y. : 1991)|May 8, 2020
Neurophysiological and Cognitive Correlates of Error Processing Deficits in Internet Gaming DisorderMinkyung Park, Myung Hun Jung, Jiyoon Lee, et al.
Anticancer Research|December 30, 2025
Immune Microenvironment Signatures Predict Response and Survival in Rectal Cancer Patients After Neoadjuvant ChemoradiationBo-Hyung Kim, Jiyoon Lee, Donghwan Lee, et al.
Translational Psychiatry|May 2, 2021
Event-related brain response to visual cues in individuals with Internet gaming disorder: relevance to attentional bias and decision-makingBo-Mi Kim, Jiyoon Lee, A Ruem Choi, et al.
Advanced Materials (Deerfield Beach, Fla.)|November 3, 2025
Synergistic Coupling of Host and Electrolyte Achieving 1270 Wh L<sup>-1</sup> in Anode-Free Lithium Metal BatteriesDong-Yeob Han, Saehun Kim, Junsu Son, et al.
Journal of Clinical Medicine|July 28, 2019
The Mediating Effects of Affect on Associations between Impulsivity or Resilience and Internet Gaming DisorderDaun Shin, A Ruem Choi, Jiyoon Lee, et al.
Stem Cell Reports|June 18, 2019
Defective Tmprss3-Associated Hair Cell Degeneration in Inner Ear OrganoidsPei-Ciao Tang, Alpha L Alex, Jing Nie, et al.
Diagnostics (Basel, Switzerland)|April 30, 2021
Relationship between Brain Tissue Changes and Blood Biomarkers of Cyclophilin A, Heme Oxygenase-1, and Inositol-Requiring Enzyme 1 in Patients with Alzheimer's DiseaseHyon-Il Choi, Kiyoon Kim, Jiyoon Lee, et al.
Nature Protocols|June 2, 2025
Generation and characterization of vestibular inner ear organoids from human pluripotent stem cellsWouter H van der Valk, Carl Nist-Lund, Jingyuan Zhang, et al.
Diagnostics (Basel, Switzerland)|February 25, 2022
Myelin-Weighted Imaging Presents Reduced Apparent Myelin Water in Patients with Alzheimer's DiseaseSeung-Hyun Lim, Jiyoon Lee, Sumin Jung, et al.
Clinical and Experimental Rheumatology|July 12, 2021
Comparison of the efficacy and safety of LBAL, a candidate adalimumab biosimilar, and adalimumab reference product in patients with active rheumatoid arthritis inadequately responding to methotrexate: a 52-week phase III randomised studyHiroaki Matsuno, Young Mo Kang, Masato Okada, et al.
Pageof 7